Navigation Links
Mystery Surrounding Use Of Abortion Pill Yet To Be Resolved

Reports of the death of four Californian women due to the toxic shock syndrome following consumption of the abortion pill RU-486 (Mifeprex) has created much confusion // and controversy among members of the scientific community.

It has been confirmed by health officials that it is due to the toxins produced by the highly lethal bacteria - Clostridium sordellii. So far, there have been only 10 reports of the fatal infection, 8 of which were in women who had given birth to live infants. One other was associated with an abortion, and the remaining one was not associated with pregnancy at all. It is still unclear if something in the abortion pill that could have caused the tragedy by increasing the chances of the infection.

Identifying C. sordellii infection in women who have induced abortion is complicated owing to the fact that there is similarity between the symptoms in by the fact that early symptoms (abdominal cramping, nausea, vomiting) tend to be the same as those experienced normally.

The abortion pill was first approved for termination of early pregnancy (7 week duration or less) in the United States in the year 2000. Since then, more than 460,000 doses of the medication have been distributed.

If the four deaths were the only ones to have occurred after using the drug, probably it would indicate that women who use it for induced abortion face a higher risk of contracting the infection. This would be approximate to a 10 times higher than the risk associated with surgical abortions performed early in pregnancy.

The biggest mystery relating to the tragedy is the incidence of all four cases in a single state while the FDA confirms the uniform frequency of drug usage throughout California. The CDC is hoping to raise awareness about the potential risks with the new report.

In view of the above report, may be it is time for doctors to closely examine the potential risks of any medication prescribed and keep a watch over any specific symptoms that could be a sign of the impending mortality.


'"/>




Related medicine news :

1. Mystery behind Preeclampsia uncovered
2. Understanding The Mystery Behind Sleepless Nights
3. Mystery of nacrolepsy uncovered
4. Cholesterol Mystery Solved By Nobel Laureates
5. A Step Towards Unraveling The Schizophrenia And Depression Mystery
6. $2.4 Million Grant To Unravel The Mystery Of Language Recognition.
7. Mystery behind Brain activity during recalling events disentangled
8. Mystery over bird flu infection to Ms. Zhou – China’s 7th bird flu victm
9. Mystery Of The Placebo Effect, Yet To Be Solved
10. Dry Earwax Mystery Solved: Ear Wax Gene Identified
11. Mystery Behind The Déjà Vu Phenomenon Yet To Be Resolvd
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer ... East-coast edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes ... 40 speakers — representing such thought-leading companies as JP Morgan Chase, GE ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy ... industry-leading compliance software, The Guard®, has helped another long-time client pass their Department ... and properly satisfy the law. , Thanks to the help of the Compliancy ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... campaign, “Humans With Vaginas.” The goal is to ignite conversation via social media ... care products. The brand has declared September “Humans with Vaginas” month, releasing a ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... millions of older Americans at risk of price gouging for their prescription drugs, ... League (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency ...
(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take on one ... better one’s life through God. “The Trials I Face to Receive God’s Grace” is ... found a love for writing. Green feels that expressing his feelings through prayer will ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... 2017   BioLife Solutions , Inc. (NASDAQ: ... clinical grade cell and tissue hypothermic storage and ... Rice , President and CEO, will be presenting at two ... & Renshaw 19 th Annual Global Investment Conference on ... Pacific time). The conference is being held at the New ...
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... -- NeuroRx, a clinical stage biopharma company developing the first ... been granted Fast Track status by the US Food and ... followed by NRX-101 (D-cycloserine + lurasidone). The company will shortly ... therapy targeting patients who are admitted to Emergency Departments with ... ...
Breaking Medicine Technology: